Πλοήγηση ανά Συγγραφέα "Zagouri, F."

Αποτελέσματα 1-3 από 3

Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer

Pentheroudakis, G.; Kotoula, V.; Kouvatseas, G.; Charalambous, E.; Dionysopoulos, D.; Zagouri, F.; Koutras, A.; Papazisis, K.; Pectasides, D.; Samantas, E.; Dimopoulos, M. A.; Papandreou, C. N.; Fountzilas, G. (2014)

We studied tissue mRNA levels of VEGF-Axxxa angiogenic versus VEGF-Axxxb anti-angiogenic isoforms by means of specially designed PCR assays in two parallel cohorts of metastatic breast cancer patients, one treated with ...
Immunoglobulin D myeloma: Clinical features and outcome in the era of novel agents

Zagouri, F.; Kastritis, E.; Symeonidis, A. S.; Giannakoulas, N.; Katodritou, E.; Delimpasi, S.; Repousis, P.; Terpos, E.; Dimopoulos, M. A. (2014)

Objectives: Immunoglobulin D (IgD) multiple myeloma is an uncommon variant of the disease probably associated with poorer prognosis. However, data on IgD myeloma patients treated in the novel agent era are lacking. Methods: ...
Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer

Bamias, A.; Karadimou, A.; Lampaki, S.; Aravantinos, G.; Xanthakis, I.; Papandreou, C.; Lainakis, G.; Zagouri, F.; Soupos, N.; Kostouros, E.; Samantas, E.; Hatzimouratidis, C.; Konstantinidis, C.; Deliveliotis, C.; Pectasides, D. G.; Fountzilas, G.; Dimopoulos, M. A.; Hellenic Cooperative Oncology, Grp (2011)

Πλοήγηση ανά Συγγραφέα "Zagouri, F."

Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer ﻿

Immunoglobulin D myeloma: Clinical features and outcome in the era of novel agents ﻿

Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer ﻿

Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer

Immunoglobulin D myeloma: Clinical features and outcome in the era of novel agents

Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer